The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed) |
93.172 |
RFA-HG-20-014 |
Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed) |
93.172 |
RFA-HG-20-015 |
Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) |
93.242 |
PA-20-141 |
U.S. Embassy Praia Ambassador's Special Self-Help (SSH) Program |
19.700 |
AFPRA-20-04 |
Research and Development in Forensic Science for Criminal Justice Purposes, Fiscal Year 2020 |
16.560 |
NIJ-2020-17294 |
Research on Juvenile Reoffending, Fiscal Year 2020 |
16.560 |
NIJ-2020-18254 |
Research and Evaluation for the Testing and Interpretation of Physical Evidence in Publicly Funded Forensic Laboratories, Fiscal Year 2020 |
16.560 |
NIJ-2020-17293 |
Patient-oriented Research to Mitigate Health Disparities and Lessen the Burden of Chronic Diseases Within the Mission of NIDDK (R01 Clinical Trial Optional) |
93.847 |
RFA-DK-20-015 |
Incorporating cost effectiveness & societal outcomes into FDA opioids model (U01) Clinical Trials Not Allowed |
93.103 |
RFA-FD-20-031 |
Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional |
93.103 |
RFA-FD-20-030 |
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional) |
93.393, 93.394, 93.399 |
RFA-CA-20-028 |
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional) |
93.393, 93.394, 93.399 |
RFA-CA-20-027 |
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) |
93.847 |
PAR-20-140 |
Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional) |
93.213 |
PAR-20-138 |
Joint FY20 Bioenergy and Advanced Manufacturing FOA BOTTLE: Bio-Optimized Technologies to keep Thermoplastics out of Landfills and the Environment |
81.086, 81.087 |
DE-FOA-0002245 |
Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R21 Clinical Trial Not Allowed) |
93.121 |
RFA-DE-20-007 |
Postdoctoral Training in Pediatric Clinical Pharmacology (T32 Clinical Trial Not Allowed) |
93.865 |
RFA-HD-21-014 |
Population Dynamics Centers Research Infrastructure Program FY 2021 (P2C Clinical Trial Not Allowed) |
93.865 |
RFA-HD-21-010 |
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) |
93.855, 93.866 |
PAR-20-139 |
Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R01 Clinical Trial Not Allowed) |
93.121 |
RFA-DE-20-006 |
Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (U24 Clinical Trial Optional) |
93.839 |
RFA-HL-21-007 |
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
93.121, 93.313, 93.865 |
PAR-20-137 |
Artificial Intelligence and Technology Collaboratories for Aging Research Coordinating Center (AITCC) (R24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-018 |
Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional) |
93.839 |
RFA-HL-21-009 |
Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional) |
93.839 |
RFA-HL-21-008 |
Artificial Intelligence and Technology Collaboratories for Aging Research (P30 Clinical Trial Optional) |
93.866 |
RFA-AG-21-009 |
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed) |
93.172 |
RFA-HG-20-019 |
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
93.393, 93.394, 93.395, 93.396 |
PAR-20-131 |
Pregnancy Risk Assessment Monitoring System (PRAMS) |
93.946 |
RFA-DP-21-001 |
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) |
93.393 |
PAR-20-136 |
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed) |
93.847 |
RFA-DK-20-006 |
Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required) |
93.393, 93.847 |
PAR-20-134 |
Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) |
93.855 |
RFA-AI-20-028 |
Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required) |
93.393, 93.847 |
PAR-20-133 |
Alzheimers Disease Research Centers (P30 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-019 |
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) |
93.113, 93.142, 93.143, 93.172, 93.213, 93.307, 93.393, 93.394, 93.395, 93.396, 93.399, 93.847, 93.855, 93.859, 93.865 |
PA-20-135 |
NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (BMOR) (P30 - Clinical Trials Not Allowed) |
93.846 |
RFA-AR-21-004 |
SBIR/STTR FY 2020 Phase II Release 2 |
81.049 |
DE-FOA-0002156 |
Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-015 |
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) |
93.394, 93.395 |
RFA-CA-20-033 |
Search Results 5001-5040 of 21428 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 [Next] |